nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route
|
Denis, Martine |
|
2019 |
37 |
S1 |
p. A99-A106 |
artikel |
2 |
A social justice perspective on access to human rabies vaccines
|
Wentworth, Diorbhail |
|
2019 |
37 |
S1 |
p. A3-A5 |
artikel |
3 |
Cost-effectiveness modelling studies of all preventive measures against rabies: A systematic review
|
Anothaisintawee, Thunyarat |
|
2019 |
37 |
S1 |
p. A146-A153 |
artikel |
4 |
Descriptive assessment of rabies post-exposure prophylaxis procurement, distribution, monitoring, and reporting in four Asian countries: Bangladesh, Bhutan, Cambodia, and Sri Lanka, 2017–2018
|
Li, Anyie J. |
|
2019 |
37 |
S1 |
p. A14-A19 |
artikel |
5 |
Editorial
|
Cravioto, Alejandro |
|
2019 |
37 |
S1 |
p. A1 |
artikel |
6 |
Editorial Board/Aims and Scope
|
|
|
2019 |
37 |
S1 |
p. IFC |
artikel |
7 |
Evaluating new rabies post-exposure prophylaxis (PEP) regimens or vaccines
|
Tarantola, Arnaud |
|
2019 |
37 |
S1 |
p. A88-A93 |
artikel |
8 |
Evaluation of Vietnam’s post-exposure prophylaxis delivery system, 2017
|
Nguyen, Huong TT. |
|
2019 |
37 |
S1 |
p. A20-A27 |
artikel |
9 |
Global characteristics of the rabies biologics market in 2017
|
Ives, Annette |
|
2019 |
37 |
S1 |
p. A73-A76 |
artikel |
10 |
Healthcare utilization, provisioning of post-exposure prophylaxis, and estimation of human rabies burden in Madagascar
|
Rajeev, Malavika |
|
2019 |
37 |
S1 |
p. A35-A44 |
artikel |
11 |
Intradermal rabies post-exposure prophylaxis can be abridged with no measurable impact on clinical outcome in Cambodia, 2003–2014
|
Tarantola, Arnaud |
|
2019 |
37 |
S1 |
p. A118-A127 |
artikel |
12 |
Introduction of intradermal rabies vaccination – A paradigm shift in improving post-exposure prophylaxis in Asia
|
Gongal, Gyanendra |
|
2019 |
37 |
S1 |
p. A94-A98 |
artikel |
13 |
Modelling to inform prophylaxis regimens to prevent human rabies
|
Hampson, Katie |
|
2019 |
37 |
S1 |
p. A166-A173 |
artikel |
14 |
New human rabies vaccines in the pipeline
|
Fooks, Anthony R. |
|
2019 |
37 |
S1 |
p. A140-A145 |
artikel |
15 |
On the path to rabies elimination: The need for risk assessments to improve administration of post-exposure prophylaxis
|
Rysava, K. |
|
2019 |
37 |
S1 |
p. A64-A72 |
artikel |
16 |
Overview of rabies post-exposure prophylaxis access, procurement and distribution in selected countries in Asia and Africa, 2017–2018
|
Sreenivasan, N. |
|
2019 |
37 |
S1 |
p. A6-A13 |
artikel |
17 |
Preface
|
Abela-Ridder, Bernadette |
|
2019 |
37 |
S1 |
p. A2 |
artikel |
18 |
Priorities in applied research to ensure programmatic success in the global elimination of canine rabies
|
Rupprecht, Charles E. |
|
2019 |
37 |
S1 |
p. A77-A84 |
artikel |
19 |
Rabies post-exposure prophylaxis: A systematic review on abridged vaccination schedules and the effect of changing administration routes during a single course
|
Kessels, Joss |
|
2019 |
37 |
S1 |
p. A107-A117 |
artikel |
20 |
Rabies post-exposure prophylaxis initiation and adherence among patients in Vietnam, 2014–2016
|
Tran, Cuc H. |
|
2019 |
37 |
S1 |
p. A54-A63 |
artikel |
21 |
Rabies vaccine and immunoglobulin supply and logistics: Challenges and opportunities for rabies elimination in Kenya
|
Wambura, Gati |
|
2019 |
37 |
S1 |
p. A28-A34 |
artikel |
22 |
Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: A review of the current status of the clinical development pipeline
|
Sparrow, Erin |
|
2019 |
37 |
S1 |
p. A132-A139 |
artikel |
23 |
The impact of transmission dynamics of rabies control: Systematic review
|
Rattanavipapong, Waranya |
|
2019 |
37 |
S1 |
p. A154-A165 |
artikel |
24 |
The need to improve access to rabies post-exposure vaccines: Lessons from Tanzania
|
Changalucha, Joel |
|
2019 |
37 |
S1 |
p. A45-A53 |
artikel |
25 |
The WHO position on rabies immunization – 2018 updates
|
O'Brien, Katherine L. |
|
2019 |
37 |
S1 |
p. A85-A87 |
artikel |
26 |
Wound-only injection of rabies immunoglobulin (RIG) saves lives and costs less than a dollar per patient by “pooling strategy”
|
Bharti, Omesh Kumar |
|
2019 |
37 |
S1 |
p. A128-A131 |
artikel |